Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs: A comparative analysis with peripheral blood and bone marrow

Erin M. Clark, Deepa S. Joshi, Andrew B. Grimm, Avadhut D. Joshi, Peng Wang, Shantaram S. Joshi

Research output: Contribution to journalArticle

Abstract

Umbilical cord blood cells (UCBC) are a rich source of immature immune effector and accessory cells, including dendritic cells. UCBC-derived cytotoxic T lymphocytes (CTLs) generated against human breast cancer or neuroblastoma have shown an increased tumor-specific cytotoxicity compared to peripheral blood (PB)-derived CTLs. The precise mechanism of this increased cytotoxicity is not known. Since dendritic cells (DCs) play a central role in the immunostimulation, we compared the ultrastructure and antigen presenting nature of DCs from UCBC, PB and bone marrow (BM) at various stages of maturation using scanning and transmission electron microscopy as well as fluorescent microscopy to elucidate the mechanism underlying the increased cytotoxicity of UCBC-derived CTLs. DCs were examined for their immunophenotype nuclear morphology, dendritic processes and cytoplasmic endosomal vesicles after 0, 3, 7 and 10 days in culture with antigen priming on day 6. Results showed that there were smaller and more vesicles in UCB-DCs compared to DCs from the other two sources, while the endosomal vesicles in PB-DCs were heterogenous in size. The antigen processing ability of the UCB-DCs showed an increase in antigen-positive endosomes compared to PB-DCs as determined by the fluorescent microscopy. Thus, our results provided the comparative analyses of DCs from cord blood, peripheral blood and bone marrow, and suggested that UCBC-DCs might have better antigen presenting ability leading to increased CTL-mediated antitumor cytotoxicity.

Original languageEnglish (US)
Pages (from-to)645-653
Number of pages9
JournalInternational Journal of Oncology
Volume37
Issue number3
DOIs
StatePublished - Sep 2010
Externally publishedYes

Fingerprint

Cytotoxic T-Lymphocytes
Fetal Blood
Dendritic Cells
Bone Marrow
Blood Cells
Antigens
Microscopy
Cytoplasmic Vesicles
Scanning Transmission Electron Microscopy
Endosomes
Antigen Presentation
Neuroblastoma
Immunization
Breast Neoplasms

Keywords

  • Antigen processing
  • Bone marrow
  • Cord blood
  • Dendritic cells
  • Peripheral blood
  • Ultrastructure

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs : A comparative analysis with peripheral blood and bone marrow. / Clark, Erin M.; Joshi, Deepa S.; Grimm, Andrew B.; Joshi, Avadhut D.; Wang, Peng; Joshi, Shantaram S.

In: International Journal of Oncology, Vol. 37, No. 3, 09.2010, p. 645-653.

Research output: Contribution to journalArticle

Clark, Erin M. ; Joshi, Deepa S. ; Grimm, Andrew B. ; Joshi, Avadhut D. ; Wang, Peng ; Joshi, Shantaram S. / Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs : A comparative analysis with peripheral blood and bone marrow. In: International Journal of Oncology. 2010 ; Vol. 37, No. 3. pp. 645-653.
@article{891d92e98a9c4ff99babca8c71a49854,
title = "Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs: A comparative analysis with peripheral blood and bone marrow",
abstract = "Umbilical cord blood cells (UCBC) are a rich source of immature immune effector and accessory cells, including dendritic cells. UCBC-derived cytotoxic T lymphocytes (CTLs) generated against human breast cancer or neuroblastoma have shown an increased tumor-specific cytotoxicity compared to peripheral blood (PB)-derived CTLs. The precise mechanism of this increased cytotoxicity is not known. Since dendritic cells (DCs) play a central role in the immunostimulation, we compared the ultrastructure and antigen presenting nature of DCs from UCBC, PB and bone marrow (BM) at various stages of maturation using scanning and transmission electron microscopy as well as fluorescent microscopy to elucidate the mechanism underlying the increased cytotoxicity of UCBC-derived CTLs. DCs were examined for their immunophenotype nuclear morphology, dendritic processes and cytoplasmic endosomal vesicles after 0, 3, 7 and 10 days in culture with antigen priming on day 6. Results showed that there were smaller and more vesicles in UCB-DCs compared to DCs from the other two sources, while the endosomal vesicles in PB-DCs were heterogenous in size. The antigen processing ability of the UCB-DCs showed an increase in antigen-positive endosomes compared to PB-DCs as determined by the fluorescent microscopy. Thus, our results provided the comparative analyses of DCs from cord blood, peripheral blood and bone marrow, and suggested that UCBC-DCs might have better antigen presenting ability leading to increased CTL-mediated antitumor cytotoxicity.",
keywords = "Antigen processing, Bone marrow, Cord blood, Dendritic cells, Peripheral blood, Ultrastructure",
author = "Clark, {Erin M.} and Joshi, {Deepa S.} and Grimm, {Andrew B.} and Joshi, {Avadhut D.} and Peng Wang and Joshi, {Shantaram S.}",
year = "2010",
month = "9",
doi = "10.3892/ijo-00000713",
language = "English (US)",
volume = "37",
pages = "645--653",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs

T2 - A comparative analysis with peripheral blood and bone marrow

AU - Clark, Erin M.

AU - Joshi, Deepa S.

AU - Grimm, Andrew B.

AU - Joshi, Avadhut D.

AU - Wang, Peng

AU - Joshi, Shantaram S.

PY - 2010/9

Y1 - 2010/9

N2 - Umbilical cord blood cells (UCBC) are a rich source of immature immune effector and accessory cells, including dendritic cells. UCBC-derived cytotoxic T lymphocytes (CTLs) generated against human breast cancer or neuroblastoma have shown an increased tumor-specific cytotoxicity compared to peripheral blood (PB)-derived CTLs. The precise mechanism of this increased cytotoxicity is not known. Since dendritic cells (DCs) play a central role in the immunostimulation, we compared the ultrastructure and antigen presenting nature of DCs from UCBC, PB and bone marrow (BM) at various stages of maturation using scanning and transmission electron microscopy as well as fluorescent microscopy to elucidate the mechanism underlying the increased cytotoxicity of UCBC-derived CTLs. DCs were examined for their immunophenotype nuclear morphology, dendritic processes and cytoplasmic endosomal vesicles after 0, 3, 7 and 10 days in culture with antigen priming on day 6. Results showed that there were smaller and more vesicles in UCB-DCs compared to DCs from the other two sources, while the endosomal vesicles in PB-DCs were heterogenous in size. The antigen processing ability of the UCB-DCs showed an increase in antigen-positive endosomes compared to PB-DCs as determined by the fluorescent microscopy. Thus, our results provided the comparative analyses of DCs from cord blood, peripheral blood and bone marrow, and suggested that UCBC-DCs might have better antigen presenting ability leading to increased CTL-mediated antitumor cytotoxicity.

AB - Umbilical cord blood cells (UCBC) are a rich source of immature immune effector and accessory cells, including dendritic cells. UCBC-derived cytotoxic T lymphocytes (CTLs) generated against human breast cancer or neuroblastoma have shown an increased tumor-specific cytotoxicity compared to peripheral blood (PB)-derived CTLs. The precise mechanism of this increased cytotoxicity is not known. Since dendritic cells (DCs) play a central role in the immunostimulation, we compared the ultrastructure and antigen presenting nature of DCs from UCBC, PB and bone marrow (BM) at various stages of maturation using scanning and transmission electron microscopy as well as fluorescent microscopy to elucidate the mechanism underlying the increased cytotoxicity of UCBC-derived CTLs. DCs were examined for their immunophenotype nuclear morphology, dendritic processes and cytoplasmic endosomal vesicles after 0, 3, 7 and 10 days in culture with antigen priming on day 6. Results showed that there were smaller and more vesicles in UCB-DCs compared to DCs from the other two sources, while the endosomal vesicles in PB-DCs were heterogenous in size. The antigen processing ability of the UCB-DCs showed an increase in antigen-positive endosomes compared to PB-DCs as determined by the fluorescent microscopy. Thus, our results provided the comparative analyses of DCs from cord blood, peripheral blood and bone marrow, and suggested that UCBC-DCs might have better antigen presenting ability leading to increased CTL-mediated antitumor cytotoxicity.

KW - Antigen processing

KW - Bone marrow

KW - Cord blood

KW - Dendritic cells

KW - Peripheral blood

KW - Ultrastructure

UR - http://www.scopus.com/inward/record.url?scp=77956527811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956527811&partnerID=8YFLogxK

U2 - 10.3892/ijo-00000713

DO - 10.3892/ijo-00000713

M3 - Article

C2 - 20664933

AN - SCOPUS:77956527811

VL - 37

SP - 645

EP - 653

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 3

ER -